184 related articles for article (PubMed ID: 16489585)
21. UV-light-induced conversion and aggregation of prion proteins.
Redecke L; Binder S; Elmallah MI; Broadbent R; Tilkorn C; Schulz B; May P; Goos A; Eich A; Rübhausen M; Betzel C
Free Radic Biol Med; 2009 May; 46(10):1353-61. PubMed ID: 19249347
[TBL] [Abstract][Full Text] [Related]
22. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
23. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
24. Singular efficacy of trimethylamine N-oxide to counter protein destabilization in ice.
Strambini GB; Gonnelli M
Biochemistry; 2008 Mar; 47(11):3322-31. PubMed ID: 18293933
[TBL] [Abstract][Full Text] [Related]
25. Copper-dependent degradation of recombinant ovine prion protein. Phosphatidylinositol stimulates aggregation and copper-driven disappearance of prion protein.
Tsiroulnikov K; Chobert JM; Haertlé T
FEBS J; 2006 May; 273(9):1959-65. PubMed ID: 16640559
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanism for low pH triggered misfolding of the human prion protein.
DeMarco ML; Daggett V
Biochemistry; 2007 Mar; 46(11):3045-54. PubMed ID: 17315950
[TBL] [Abstract][Full Text] [Related]
27. Effect of osmolytes on pressure-induced unfolding of proteins: a high-pressure SAXS study.
Krywka C; Sternemann C; Paulus M; Tolan M; Royer C; Winter R
Chemphyschem; 2008 Dec; 9(18):2809-15. PubMed ID: 18924198
[TBL] [Abstract][Full Text] [Related]
28. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
29. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
30. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
31. Local environmental effects on the structure of the prion protein.
DeMarco ML; Daggett V
C R Biol; 2005; 328(10-11):847-62. PubMed ID: 16286076
[TBL] [Abstract][Full Text] [Related]
32. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
33. Thermodynamic and voltammetric characterization of the metal binding to the prion protein: insights into pH dependence and redox chemistry.
Davies P; Marken F; Salter S; Brown DR
Biochemistry; 2009 Mar; 48(12):2610-9. PubMed ID: 19196019
[TBL] [Abstract][Full Text] [Related]
34. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
Bertho G; Bouvier G; Hoa GH; Girault JP
Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
[TBL] [Abstract][Full Text] [Related]
35. The conversion of helix H2 to beta-sheet is accelerated in the monomer and dimer of the prion protein upon T183A mutation.
Chebaro Y; Derreumaux P
J Phys Chem B; 2009 May; 113(19):6942-8. PubMed ID: 19371053
[TBL] [Abstract][Full Text] [Related]
36. Folding and intrinsic stability of deletion variants of PrP(121-231), the folded C-terminal domain of the prion protein.
Eberl H; Glockshuber R
Biophys Chem; 2002 May; 96(2-3):293-303. PubMed ID: 12034448
[TBL] [Abstract][Full Text] [Related]
37. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
38. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
Thackray AM; Hopkins L; Bujdoso R
Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
[TBL] [Abstract][Full Text] [Related]
39. Cu(II) induces small-size aggregates with amyloid characteristics in two alleles of recombinant ovine prion proteins.
Tsiroulnikov K; Rezaei H; Dalgalarrondo M; Chobert JM; Grosclaude J; Haertlé T
Biochim Biophys Acta; 2006 Jul; 1764(7):1218-26. PubMed ID: 16777497
[TBL] [Abstract][Full Text] [Related]
40. Structural insights into alternate aggregated prion protein forms.
Polano M; Bek A; Benetti F; Lazzarino M; Legname G
J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
